{"id":"NCT00572572","sponsor":"Hoosier Cancer Research Network","briefTitle":"Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors","officialTitle":"Phase III, Double-Blind, Placebo-Controlled, Crossover Study Evaluating Aprepitant in Combination With a 5HT3 & Dexamethasone in Patients With Germ Cell Tumors Undergoing 5 Day Cisplatin-Based Chemotherapy Regimen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2010-12","completion":"2011-02","firstPosted":"2007-12-13","resultsPosted":"2016-04-06","lastUpdate":"2016-04-06"},"enrollment":69,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Germ Cell Tumors"],"interventions":[{"type":"DRUG","name":"Aprepitant","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm A: Aprepitant, Then Placebo","type":"EXPERIMENTAL"},{"label":"Arm B: Placebo, Then Aprepitant","type":"EXPERIMENTAL"}],"summary":"Aprepitant is currently approved for prophylaxis of acute and delayed CINV for highly emetogenic chemotherapy regimens, including cisplatin; however, it has not yet been studied in multiple-day chemotherapy treatment programs. This study will compare the addition of aprepitant compared to placebo administered on days 3,4,5 of chemotherapy administration for acute CINV prophylaxis with standard antiemetic prophylaxis and days 6 and 7 for delayed CINV prophylaxis in a double-blind, randomized, crossover study design.","primaryOutcome":{"measure":"Complete Response.","timeFrame":"Participants were evaluated from start of treatment through day 8 of cycle 2.","effectByArm":[{"arm":"Aprepitant","deltaMin":47,"sd":null},{"arm":"Placebo","deltaMin":15,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["22915652"],"seeAlso":["http://www.hoosieroncologygroup.org"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":35},"commonTop":["NAUSEA","FATIGUE (ASTHENIA, LETHARGY, MALAISE)","HAIR LOSS/ALOPECIA (SCALP OR BODY)","HEARTBURN/DYSPEPSIA","INSOMNIA"]}}